Does OLAPARIB Cause Thrombocytopenia? 315 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 315 reports of Thrombocytopenia have been filed in association with OLAPARIB (Lynparza). This represents 1.7% of all adverse event reports for OLAPARIB.
315
Reports of Thrombocytopenia with OLAPARIB
1.7%
of all OLAPARIB reports
60
Deaths
84
Hospitalizations
How Dangerous Is Thrombocytopenia From OLAPARIB?
Of the 315 reports, 60 (19.0%) resulted in death, 84 (26.7%) required hospitalization, and 35 (11.1%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which OLAPARIB Alternatives Have Lower Thrombocytopenia Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL